← FDA Drug Approvals (Drugs@FDA)
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2012-12-04
Drug application
- FDA Application #
ANDA090704- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
- Generic name
- CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
- Active ingredients
- CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PHARMOBEDIENT
- Manufacturer
- Mylan Pharmaceuticals Inc.
- First approval
- 2012-12-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown